NCT05282342 is a clinical trial of Diagnostic tests in Disease, Chronic, sponsored by Luis Santos.

Who is sponsoring NCT05282342?

NCT05282342 is sponsored by Luis Santos.

What drugs are being tested in NCT05282342?

Interventions in NCT05282342: Diagnostic tests.

What condition does NCT05282342 study?

NCT05282342 studies Disease, Chronic.

Is NCT05282342 still recruiting?

NCT05282342 is currently completed. Last updated 30 April 2024.

Last reviewed 2024-04-30 · How we verify

NCT05282342

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Heart Transplant Patients, Health Status and Physical Activity

Completed Last updated 30 April 2024

What this trial tests

trial testing Diagnostic tests in Disease, Chronic in 72 participants. Completed in 30 June 2022.

Timeline

10 January 2022

Primary endpoint
10 January 2022

30 June 2022

Quick facts

Lead sponsor	Luis Santos
Status	Completed
Study type	OBSERVATIONAL
Enrollment	72
Start date	10 January 2022
Primary completion	10 January 2022
Estimated completion	30 June 2022
Sites	1 location across Spain

Drugs / interventions tested

Diagnostic tests

Conditions studied

Disease, Chronic — all drugs for Disease, Chronic →

Sponsor

Luis Santos

Who can join

Adults 18 to 90, any sex, with Disease, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this cross-sectional observational study is (1) to assess the health status of a group of heart transplant patients and their level of physical activity, (2) and to compare the health status of a group of heart transplant patients with different levels of physical activity, with a group of healthy people classified as sedentary (due to their level of physical activity).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Diagnostic tests

Trials testing the same drug.

NCT05314270 — Evaluation of Non-B Non-C Liver Cirrhosis in A EL-Rajhi Assuit University Hospital: A Retrospective-Prospective Study · unknown
NCT04828629 — Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity · unknown
NCT04802369 — Factors and Prognostic Significance of Impaired Exercise Tolerance in Women Over 40 With Arterial Hypertension · NA · completed
NCT03481712 — Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 2 · completed

Other Luis Santos trials

Trials by the same sponsor.

NCT03486483 — Spastic Cerebral Palsy and Slackline · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05282342 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Luis Santos
Last refreshed: 30 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05282342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing